Viatris | VTRS - Operating Expenses

Stock Price
13.50
Daily Change
-0.01 -0.07%
Monthly
-14.23%
Yearly
45.95%
Q1 Forecast
13.10

Viatris reported $3.86B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Celltrion KRW 724.99B 6B Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 118.61M 11.79M Sep/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Pharma Mar EUR 46.87M 7.24M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.86B 335.7M Dec/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025